GluN3A knockout mouse: Alternative model for Alzheimer’s neurodegeneration
Public opinion surveys on vaccine hesitancy can help predict where vaccine uptake is likely to be lower
28 June 2021US emerging from pandemic, but COVID will cast a long shadow on American health
29 June 2021GluN3A knockout mouse: Alternative model for Alzheimer’s neurodegeneration
In recent debate over the FDA’s approval of the Alzheimer’s drug aducanumab, we’ve heard a lot about the “amyloid hypothesis.” In that context, it’s refreshing to learn about a model of Alzheimer’s neurodegeneration that doesn’t start with the pathogenic proteins amyloid or Tau.
